Howard University Cure Sickle Cell Now Move-On Event – 09/17/2022

Join us on September 17th, 2022 from 8:30 am – 12:00 pm for our 16th Annual Cure Sickle Cell Now Move-On Event!

Register on or before August 29th for guaranteed t-shirt. T-shirts available onsite – first come, first serve.


  • 5K Fun Walk/Run on Howard University Campus
  • Zumba Online
  • Virtual #CSCN Run/Walk Challenge on Nike Run Club App – September 1 – 16, 2022
  • Prizes, Raffles, and Vendors!
Click here to download event flyer.

Share this post

Sign up for our email list, or follow us on social media, to stay in-the-know about the Maryland Sickle Cell Disease Association
Scroll to Top

Breaking News

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

On December 8, 2023, “The U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy."